Share on LinkedInShare on LinkedIn

ARTICLE · 05 JANUARY 2009

Intellectual Property 2008/2009 Winter Bulletin

Personalized medicine companies should implement new strategies to deal with the challenges associated with protecting their inventions.

United StatesIntellectual Property

CONTENTS

  • Protecting Patents for Personalized Medicine
  • The Fallout From Bilski: Significant Change in What is Considered Patentable
  • Quick Updates
  • Ninth Circuit Applies Its Implied License Test to Software
  • Minsky v. Linden Research Inc. – Tiffany v. eBay Revisited
  • Consideration of Prior Art by Courts Does Not Bar Subsequent Consideration in Reexaminations
  • California Supreme Court Rejects the "Narrow Restraint" Exception to Noncompetition Agreements

Protecting Patents for Personalized Medicine
By Michael J. Shuster, Ph.D. And Pauline Farmer-Koppenol

Personalized medicine companies should implement new strategies to deal with the challenges associated with protecting their inventions. Personalized medicine uses various types of diagnostic information to improve outcomes and reduce healthcare costs by determining in advance whether a patient is likely to respond to a proposed treatment.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from